NANOSOMIX INC has a total of 32 patent applications. It decreased the IP activity by 14.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, Israel and EPO (European Patent Office). Its main competitors in its focus markets measurement, biotechnology and pharmaceuticals are GOETZL EDWARD J, BIODTECH INC and BELGIAN VOLITION SPRL.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | Israel | 6 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | WIPO (World Intellectual Property Organization) | 5 | |
#5 | Canada | 3 | |
#6 | Taiwan | 2 | |
#7 | Japan | 1 | |
#8 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Biotechnology | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Measuring microorganism processes | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Goetzl Edward J | 15 |
#2 | Mitsuhashi Masato | 8 |
#3 | Edward J Goetzl | 4 |
#4 | Musuhashi Masato | 2 |
#5 | Masato Mitsuhashi | 2 |
#6 | Mitsuhashi Masato J | 1 |
Publication | Filing date | Title |
---|---|---|
WO2019144056A1 | Dectection of exosomes and exosomal biomarkers for the diagnosis and prognosis of diseases and disorders | |
EP3630947A1 | Detection of biomarkers on vesicles for the diagnosis and prognosis of diseases and disorders | |
CA3044048A1 | Quantification of subpopulations of exosomes and diagnosis of neurodegenerative disorders | |
EP3452828A1 | Synaptic protein biomarkers and differential diagnosis of alzheimer's disease and other neurodegenerative disorders | |
US2018080945A1 | Biomarkers and diagnostic methods for alzheimer's disease and other neurodegenerative disorders | |
US2016363599A1 | Biomarkers and differential diagnosis of alzheimer's disease and other neurodegenerative disorders | |
TW202102856A | Biomarkers and diagnostic methods for alzheimer's disease and other neurodegenerative disorders |